Cdc45 Limits Replicon Usage from a Low Density of preRCs in Mammalian CellsPhilip G. Wong, Mark G. Alexandrow|PLoS ONE|2011Cited by 97
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome FunctionShengyan Xiang, Mark G. Alexandrow|Molecular Cancer Therapeutics|2024Cited by 6
Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome FunctionMark G. Alexandrow, Damon R. Reed|Research Square|2023Cited by 3